Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Nuclear Mitotic Apparatus Protein 1 (NUMA1) Peptide

NUMA1 Reactivité: Mammifères Hôte: Synthetic BP, WB, IHC
N° du produit ABIN936841

Aperçu rapide pour Nuclear Mitotic Apparatus Protein 1 (NUMA1) Peptide (ABIN936841)

Antigène

NUMA1 (Nuclear Mitotic Apparatus Protein 1 (NUMA1))

Origine

Mammifères

Source

  • 2
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
  • Type de proteíne

    Synthetic

    Séquence

    AQRLQAQLNE LQAQLSQKEQ AAEHYKLQME KAKTHYDAKK QQNQELQEQL

    Attributs du produit

    A synthetic peptide for use as a blocking control in assays to test for specificity of NUMA1 antibody,
    Alternative Names: NUMA1 control peptide, NUMA1 antibody Blocking Peptide, Anti-NUMA1 Blocking Peptide, nuclear mitotic apparatus protein 1 Blocking Peptide, NUMA Blocking Peptide, NUMA1, NUMA-1, NUMA 1, NUMA-1 Blocking Peptide, NUMA 1 Blocking Peptide

    Purification

    Immunoaffinity chromatography
  • Indications d'application

    Optimal conditions should be determined by the investigator

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.

    Buffer

    PBS

    Conseil sur la manipulation

    Avoid repeated freeze/thaw cycles.

    Stock

    -20 °C

    Stockage commentaire

    Store at -20 °C long term.
  • Antigène

    NUMA1 (Nuclear Mitotic Apparatus Protein 1 (NUMA1))

    Sujet

    NuMA is a structural element in maintaining nuclear integrity. A critical spindle pole-associated mechanism, called the END (Emi1/NuMA/dynein-dynactin) network, spatially restricts APC/C activity in early mitosis. The entire coding region and exon-intron boundaries of NuMa were screened in 92 familial breast cancer patients. But the results do not support the role of NuMA variants as breast cancer susceptibility alleles.

    Poids moléculaire

    238 kDa
Vous êtes ici:
Chat with us!